Feasibility of an Intravenous Home Chemotherapy Intervention With Low‐Dose Cytarabine Administered by Parents (INTACTatHome)
The IHC intervention is a feasible, acceptable, and safe option in this specific context, allowing children to receive intravenous chemotherapy administered by their parent in the comfort of their home.
Authors
- Mary Jarden (ORCID: https://orcid.org/0000-0003-3040-8384)
- Tenna Ruest Haarmark Nielsen (ORCID: https://orcid.org/0000-0002-0684-6651)
- Helena Hansson (ORCID: https://orcid.org/0000-0002-6911-3121)
- Anders Tolver (ORCID: https://orcid.org/0000-0003-1109-9889)
- Martha Krogh Topperzer (ORCID: https://orcid.org/0000-0002-6628-5067)
- Astrid Eliasen (ORCID: https://orcid.org/0000-0002-2261-0323)
- Louise Ingerslev Roug (ORCID: https://orcid.org/0000-0002-5162-648X)
- Ayo Wahlberg (ORCID: https://orcid.org/0000-0001-6862-5208)
- Lisa Lyngsie Hjalgrim (ORCID: https://orcid.org/0000-0001-5186-3365)
- Rikke Thenning Michelsen
Institutions
- University of Copenhagen (DK)
- Statistics Denmark (DK)
- Bispebjerg Hospital (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Department of Mathematical Sciences (RU)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1002/pbc.31965
- Primary Topic
- Childhood Cancer Survivors' Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Børnecancerfonden
- Novo Nordisk